Welcome to LookChem.com Sign In|Join Free
  • or
Ethanone, 2-(4-methoxyphenyl)-1-[4-(phenylmethoxy)phenyl]- is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

187989-19-1

Post Buying Request

187989-19-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

187989-19-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 187989-19-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,8,7,9,8 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 187989-19:
(8*1)+(7*8)+(6*7)+(5*9)+(4*8)+(3*9)+(2*1)+(1*9)=221
221 % 10 = 1
So 187989-19-1 is a valid CAS Registry Number.

187989-19-1Relevant academic research and scientific papers

Biological evaluation of KRIBB3 analogs as a microtubule polymerization inhibitor

Lee, Sangku,Kim, Jae Nyoung,Lee, Hyeong Kyu,Yoon, Kab Seog,Shin, Ki Deok,Kwon, Byoung-Mog,Han, Dong Cho

, p. 977 - 979 (2011/03/21)

A series of KRIBB3 analogs were synthesized by modifying substituents at aryl moieties of KRIBB3 for examining structure-activity relationships, and their inhibitory activities on microtubule polymerization were evaluated. The presence of free phenolic hydrogens in aryl moieties of KRIBB3 analogs plays an important role in inhibition of microtubule polymerization.

1, 2 DISUBSTITUTED HETEROCYCLIC COMPOUNDS

-

Page/Page column 61-62, (2010/01/30)

1,2-disubstituted heterocyclic compounds which are inhibitors of phosphodiesterase 10 are described. Also described are processes, pharmaceutical compositions, pharmaceutical preparations and pharmaceutical use of the compounds in the treatment of mammals, including human(s) for central nervous system (CNS) disorders and other disorders which may affect CNS function. Among the disorders which may be treated are neurological, neurodegenerative and psychiatric disorders including, but not limited to, those associated with cognitive deficits or schizophrenic symptoms.

Pyridine compounds, intermediates compositions and methods of use

-

, (2008/06/13)

The present invention is directed to compounds of Formula I: STR1 wherein: n is 2 or 3; R is dimethylamino, diethylamino, 1-piperidinyl, 1-pyrrolidinyl, 4-morpholinyl, or 1-hexamethyleneimino; R1 is hydrogen, loweralkyl of C1 -C

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 187989-19-1